Get the Stockscreener App
0.00
100.00%
-2.04
After Hours:
2.04
2.04
+
Organovo Holdings Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases.
See More
Previous Close:
$2.04
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$3.10M
Revenue:
-
Net Income/Loss:
$-19.09M
P/E Ratio:
0.00
EPS:
-2.17
Net Cash Flow:
$-16.92M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$21.96
Organovo Holdings Inc Stock (ONVO) Company Profile
Name
Organovo Holdings Inc
Sector
Industry
Phone
858-224-1000
Address
11555 SORRENTO VALLEY ROAD, SAN DIEGO, CA
Compare ONVO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ONVO
Organovo Holdings Inc
|
0.00 | 3.10M | 0 | -19.09M | -16.92M | -2.17 |
|
VRTX
Vertex Pharmaceuticals Inc
|
434.38 | 110.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
584.99 | 59.13B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
561.75 | 34.75B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
283.40 | 33.69B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
225.77 | 25.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Organovo Holdings Inc Stock (ONVO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-13-18 | Initiated | H.C. Wainwright | Buy |
| Nov-10-17 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jan-25-17 | Initiated | Raymond James | Outperform |
| Aug-11-15 | Downgrade | Cantor Fitzgerald | Buy → Hold |
| Jun-29-15 | Initiated | Jefferies | Buy |
| Jun-29-15 | Initiated | Piper Jaffray | Overweight |
View All
Organovo Holdings Inc Stock (ONVO) Latest News
Organovo (NASDAQ:ONVO) Now Covered by Analysts at StockNews.com - Defense World
Organovo Holdings, Inc. to Host Earnings Call - ACCESS Newswire
Organovo Holdings, Inc. Announces Board Appointments - marketscreener.com
Organovo Announces Close Of Sale Of FXR Program To Eli Lilly And Company - marketscreener.com
Organovo Holdings, Inc. and BICO Reach Licensing Agreement on Bioprinting Patents - marketscreener.com
VivoSim Labs introduces AI-driven drug testing models By Investing.com - Investing.com Canada
Organovo Holdings Rebrands to VivoSim Labs, Inc. - TipRanks
VivoSim Labs introduces AI-driven drug testing models - Investing.com Australia
FDA Shift Powers VivoSim's Game-Changing Drug Testing Tech: 50% Cost Reduction Target - Stock Titan
Organovo rebrands as VivoSim Labs, debuts new ticker By Investing.com - Investing.com South Africa
Organovo (ONVO) Rebrands to VivoSim Labs with New Ticker 'VIVS' - GuruFocus
Organovo (ONVO) Rebrands to VivoSim Labs with New Ticker 'VIVS' | ONVO Stock News - GuruFocus
Organovo rebrands as VivoSim Labs, debuts new ticker - Investing.com Australia
Organovo announces VivoSim to carry forward 3D bioprinting, legacy tech - TipRanks
VivoSim to Carry Forward Organovo 3D Bioprinting | ONVO Stock Ne - GuruFocus
Organovo Holdings Announces Transition to VivoSim Labs - TipRanks
VivoSim to Carry Forward Organovo 3D Bioprinting - The Manila Times
Organovo Holdings, Inc. Announces Name Change to VivoSim Labs, Inc. and New Ticker Symbol "VIVS" - Nasdaq
Strategic Transformation: Organovo Becomes VivoSim Labs to Accelerate 3D Bioprinting Innovation - Stock Titan
StockNews.com Begins Coverage on Organovo (NASDAQ:ONVO) - Defense World
Organovo stock plunges to 52-week low, touches $1.7 By Investing.com - Investing.com South Africa
Organovo (ONVO) Strengthens Position with FXR Program Sale - GuruFocus
Organovo (ONVO) Reports Preliminary Fiscal Year-End Cash Balance - GuruFocus
Organovo stock plunges to 52-week low, touches $1.7 - Investing.com Australia
Why Argenx Shares Are Trading Higher By 5%; Here Are 20 Stocks Moving Premarket - Benzinga
Eli Lilly and Company’s Acquisition of FXR Program from Organovo - Global Legal Chronicle
Organovo (NASDAQ:ONVO) Earns Sell Rating from Analysts at StockNews.com - Defense World
Organ On A Chip Market Generated Opportunities, Future Scope - openPR.com
Organovo (ONVO) Anticipates $5M Cash Influx as Nasdaq Compliance Continues - GuruFocus
Organovo reports $11.3M cash balance in FY24 - MSN
Organovo expects to maintain Nasdaq listing with stable stock price By Investing.com - Investing.com India
Organovo Provides Update on Cash and Nasdaq Continued Listing Requirements - The Manila Times
Organovo Holdings Expects to Meet Nasdaq Listing Requirements - TipRanks
Organovo expects to maintain Nasdaq listing with stable stock price - Investing.com
Organovo stock plunges to 52-week low of $2.13 amid steep decline - Investing.com Canada
ONVO Stock Quote Price and Forecast - CNN
Organovo Holdings (ONVO) Sells FXR Program to Lilly (LLY), Secures Financial Future - GuruFocus
Organovo sells FXR Program, anticipates reduced costs By Investing.com - Investing.com South Africa
Organovo gets upfront payments following sale of its FXR Program to Lilly - Seeking Alpha
Organovo Provides Business Update - Quantisnow
Organovo sells FXR Program, anticipates reduced costs - Investing.com India
Organovo Holdings Completes Sale of FXR Program to Lilly - TipRanks
Organovo Holdings Inc Stock (ONVO) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.45%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):